Zeigen Sie einen interaktiven Aktien-Chart für T2 Biosystems, Inc. (TTOO) auf NASDAQ.com an, die Quelle Ihres Vertrauens für Börsenneuigkeiten und Aktieninformationen.
The Company entered into two financing agreements that enables the potential access to up to $60 million of additional capital, potentially strengthening its financial position.
Entered into an At-the-Market (ATM) equity offering agreement with Canaccord Genuity LLC pursuant to which Canaccord will, at the Company’s option, use reasonable best efforts to sell up to $30 million of our common stock at our direction.
Entered into common stock purchase and registration rights agreements with Lincoln Park Capital Fund, LLC (LPC), a Chicago-based institutional investor, under which we will have the right and the sole discretion to sell to LPC up to $30 million worth of shares over a 36-month period at market rates based on closing prices in the past 10 days from when a sales of shares may occur, subject to certain limitations under the agreement as further described below under the section titled "Financing Agreement Details".
"...announced today that it has been awarded a milestone-based contract of initial value of $6 million with a potential value of up to $69 million, if all contract options are exercised, from the Biomedical Advanced Research and Development Authority (BARDA) ..."
Ich weiß ja nicht,’wann “du Doof” eingestiegen bist aber ich bin gut im Gewinn. Was ist bei dir schief gelaufen, dass du so austickst. Schon mal ärztliche Hilfe in Anspruch genommen?
"Management projects revenue for the full year 2020 to range from $14.0 million to $17.0 million,including product revenue between $8.0 million and $10.0 million and research and grant contribution revenue of $6.0 million to $7.0 million "
Angesichts des hohen Verlustes und des niedrigen Cashbestands bin ich eher skeptisch was die kurzfristigen Zukunftsaussichten anbetrifft. Siehe auch Posting #70
Thread abonnieren
